Steven Pipe
InvestorInvestment Committee Co-Chair at Pathway to Cures
About
Pipe is a Professor of Pediatrics and Pathology at the University of Michigan and Medical Director of its Pediatric Hemophilia and Coagulation Disorders Program, actively involved in hemophilia gene therapy trials.
Colleagues at Pathway to Cures
Amy L. Dunn
Chair, Medical and Scientific Advisory Council (MASAC) for NBDF at Pathway to Cures
Beth Whitehouse
NBDF Senior Vice President for Advancement at Pathway to Cures
Brian Andrew
Investment Committee Chair at Pathway to Cures
Christine Brennan
Investment Committee Member at Pathway to Cures
Geeta Vemuri
Managing Partner, Founder at Agent Capital
Gilbert C. White
P2C Board Vice Chair & Secretary at Pathway to Cures
Gilbert C. White, II
P2C Board Vice Chair & Secretary at Pathway to Cures
Glenn Pierce
Scientific Advisory Group Co-Chair at Pathway to Cures
Frequently asked questions
- Who is Steven Pipe?
- Pipe is a Professor of Pediatrics and Pathology at the University of Michigan and Medical Director of its Pediatric Hemophilia and Coagulation Disorders Program, actively involved in hemophilia gene therapy trials.
- Where does Steven Pipe work?
- Steven Pipe is Investment Committee Co-Chair at Pathway to Cures.